CFO sold ~$628K of ARWR shares in the open market

Past results only. Not a forecast.

Record ID

0000879407-26-000039

Filed / recorded

Apr 24, 2026, 10:44 PM UTC

Added to OQRO

Oct 6, 2026, 4:40 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

ARROWHEAD PHARMACEUTICALS, INC.

Issuer CIK

879407

Ticker

ARWR

Reporting person

Daniel Joseph Apel

Relationship

Officer

Officer title

Chief Financial Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Apr 22, 2026

Transaction code

S

Shares / units

8,730

Price per share

$71.92

Acquired / disposed

Disposed (D)

Shares owned after

162,905

Ownership form

Direct

Amendment

No

1. Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
2. Partial disposition of shares to satisfy tax withholding obligations.
3. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $71.55 to $71.97, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
4. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.